This inventor holds 3 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 1994-2002.
Company Filing History:
Years Active: 1994-2002
Title: Innovations in Magnetic Resonance Imaging by Pablo Irarrazabal
Introduction
Pablo Irarrazabal is a notable inventor based in Stanford, CA (US), recognized for his contributions to the field of magnetic resonance imaging (MRI). With a total of 3 patents, he has made significant advancements that enhance the efficiency and accuracy of MRI technology.
Latest Patents
One of Irarrazabal's latest patents is titled "Three dimensional magnetic resonance imaging using spiral trajectories in k-space." This innovation employs spiral trajectories that traverse a volume in k-space, allowing for faster coverage and reduced total scan time. The technology can utilize interleaved planar k-space trajectories that are axially rotated or planar k-space trajectories that traverse parallel slices through the volume, which can be spherical or ellipsoidal.
Another significant patent is "Magnetic field inhomogeneity correction in MRI using estimated linear." This method provides a fast and robust solution for correcting image distortion caused by field inhomogeneity during spiral k-space scanning. It involves acquiring a local field map and applying a linear map to deblur image distortions, making it effective even in low signal regions and near abrupt field changes.
Career Highlights
Pablo Irarrazabal is affiliated with Leland Stanford Junior University, where he continues to push the boundaries of MRI technology. His work has been instrumental in improving imaging techniques that are crucial for medical diagnostics.
Collaborations
Irarrzabal has collaborated with esteemed colleagues such as John Mark Pauly and Craig H Meyer, contributing to the advancement of MRI technology through shared expertise and innovative research.
Conclusion
Pablo Irarrazabal's contributions to magnetic resonance imaging reflect his dedication to enhancing medical technology. His patents demonstrate a commitment to improving diagnostic capabilities, ultimately benefiting the healthcare field.